Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPortmeirion Regulatory News (PMP)

Share Price Information for Portmeirion (PMP)

Share Price is delayed by 15 minutes
Get Live Data
51.50    0.00 (0.00%)
Bid:
50.00
Ask:
53.00
Spread: 3.00 (6.00%)
Market Cap: £24.61m
PMP Live PriceLast checked at - London Stock Exchange

Intraday Portmeirion Share Chart

Executive Share Option Grants

28 Apr 2015 16:23

RNS Number : 5893L
Portmeirion Group PLC
28 April 2015
 

 

 

 

Portmeirion Group PLC

(the "Company")

(the "Group")

 

 

 

Executive Share Option Grants

and

Directors' Dealings

 

28 April 2015

 

Executive Share Option Grants

The Company announces that, on 27 April 2015, it granted options to Directors and senior managers over a total of 165,000 Ordinary Shares pursuant to The Portmeirion 2012 Approved Share Option Plan and The Portmeirion 2012 Unapproved Share Option Plan (the '2012 Plans'). The options are subject to the achievement of performance criteria as determined by the Remuneration Committee, and as required under the 2012 Plans. The options granted on 27 April 2015 are normally only exercisable if the increase in the average of the Group's basic adjusted (for changes in accounting standards and exceptional items) earnings per share for each of the three years ending 31 December 2015, 31 December 2016 and 31 December 2017 is at least 10% higher than that for the year ended 31 December 2014.The following Directors of the Company were granted options as detailed below:

 

Number of options granted

Exercise price per Ordinary Share

Exercise period

Philip Atherton

33,000

£9.35

28 April 2018 - 26 April 2025

Lawrence Bryan

49,500

£9.35

28 April 2018 - 26 April 2025

Brett Phillips

33,000

£9.35

28 April 2018 - 26 April 2025

 

The total number of Ordinary Shares over which each Director holds options following this notification is:

 

Total number of options

over Ordinary Shares

Philip Atherton

94,494

Lawrence Bryan

159,473

Brett Phillips

96,027

 

Directors' Dealings

 

The Company also announces that it was notified that The Portmeirion Employees' Share Trust (the 'Trust') on 27 April 2015 purchased 119,377 Ordinary Shares from Lawrence Bryan at a price of £9.35 per Ordinary Share and 30,000 Ordinary Shares from Brett Phillips (10,000 in his name and 20,000 registered in the name of his wife, Delia Phillips) at a price of £9.35 per Ordinary Share. Following the sale, the Directors hold a beneficial interest in the following number of Ordinary Shares:

 

 

Total number of

Ordinary Shares held

% of the issued share capital of the Company with voting rights

Lawrence Bryan

124,228

1.16%

Brett Phillips

90,548

0.84%

 

The remainder of the Ordinary Shares required to satisfy the above share option grants will be newly issued shares or shares transferred from those held in treasury by the Company.

 

 

 

ENQUIRIES:

 

Portmeirion Group PLC:

Dick Steele

Non-executive Chairman

+44 (0) 1782 744 721

steele_clan@msn.com

Brett Phillips

+44 (0) 1782 744 721

bphillips@portmeiriongroup.com

Group Finance Director

 

Bell Pottinger

Dan de Belder

+44 (0) 203 772 2561

ddebelder@bellpottinger.com

Kashara Taylor

+44 (0) 203 772 2593

ktaylor@bellpottinger.com

Panmure Gordon (Nominated Adviser and Broker)

+44 (0) 207 886 2500

Freddy Crossley / Duncan Monteith

Corporate Finance

Tom Salvesen / Maisie Atkinson

Corporate Broking

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBUGDSCBDBGUI
Date   Source Headline
25th May 20212:44 pmRNSResult of AGM
25th May 20217:00 amRNSAGM Trading Statement
25th Mar 20215:35 pmRNSGrant of Options and Director Dealings
18th Mar 20217:00 amRNSPreliminary Results
3rd Mar 20217:00 amRNSInvestor results presentation
14th Jan 20217:00 amRNSTrading Update
15th Dec 20205:17 pmRNSHolding(s) in Company
4th Nov 202010:57 amRNSHolding(s) in Company
25th Sep 20209:05 amRNSExercise of Options
24th Sep 20207:00 amRNSInterim Results
17th Sep 20203:24 pmRNSHolding(s) in Company
16th Sep 20208:00 amRNSInvestor results presentation
28th Aug 202010:25 amRNSBoard Changes update
28th Aug 20209:37 amRNSHolding(s) in Company
13th Aug 20207:00 amRNSAcquisition in Portmeirion Canada
4th Aug 20207:00 amRNSBoard Changes
22nd Jul 20209:42 amRNSHolding(s) in Company
15th Jul 20207:00 amRNSHalf Year Trading Update
10th Jul 202011:46 amRNSHolding(s) in Company
1st Jul 20205:14 pmRNSHolding(s) in Company
1st Jul 20207:00 amRNSPDMR Shareholdings
29th Jun 20201:31 pmRNSResults of Open Offer and General Meeting
17th Jun 20207:41 amRNSHolding(s) in Company
10th Jun 20201:34 pmRNSResults of Placing and Notice of General Meeting
10th Jun 20207:00 amRNSProposed Placing, Subscription and Open Offer
19th May 20202:28 pmRNSAGM Resolutions
19th May 20207:00 amRNSAGM Trading Statement
12th May 20207:00 amRNSAppointment of Joint Broker
4th May 202011:42 amRNSExecutive Share Option Grants
6th Apr 202011:44 amRNSHolding(s) in Company
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:37 pmRNSPrice Monitoring Extension
30th Mar 202011:25 amRNSCovid-19 and Business Update
24th Mar 20207:00 amRNSInvestor results presentation
19th Mar 20207:00 amRNSPreliminary Results
16th Jan 20207:00 amRNSTrading Update
23rd Dec 20194:56 pmRNSHolding(s) in Company
25th Nov 20192:53 pmRNSDirector's Dealing
15th Nov 20195:22 pmRNSTotal Voting Rights - Replacement
15th Nov 20192:33 pmRNSTotal Voting Rights
14th Nov 20197:00 amRNSTrading Update
30th Sep 20194:00 pmRNSSale of Shareholding in Furlong Mills
2nd Sep 20197:00 amRNSDirectorate Change
9th Aug 20197:00 amRNSExercise of Options and PDMR Shareholdings
1st Aug 20197:00 amRNSInterim Results
22nd Jul 20193:59 pmRNSHolding(s) in Company
15th Jul 20197:00 amRNSAcquisition of Nambé LLC
17th May 20194:37 pmRNSHolding(s) in Company
16th May 20191:55 pmRNSAGM Resolutions
14th May 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.